{"slideshow_credits": null, "snippet": "The sometimes controversial pioneer in developing human embryonic stem cells will be acquired by one of the major drug companies in Japan.", "abstract": "Japanese drug company Astellas Pharma will acquire Ocata, biotechnology firm known for its work developing human embryonic stem cells, for around $379 million.", "section_name": "Business Day", "print_page": "4", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/11/11/business/international/astellas-pharma-ocata-therapeutics-acquisition.html", "lead_paragraph": "The sometimes controversial pioneer in developing human embryonic stem cells will be acquired by one of the major drug companies in Japan.", "headline": {"main": "Astellas Pharma to Acquire Ocata Therapeutics", "print_headline": "Drug Maker in a Deal for Pioneer in Stem Cells"}, "_id": "56418baf38f0d80e74ff984d", "word_count": "375", "multimedia": [{"height": 126, "url": "images/2015/11/11/business/stem-web1/stem-web1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/11/11/business/stem-web1/stem-web1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 902, "url": "images/2015/11/11/business/stem-web1/stem-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/11/business/stem-web1/stem-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "902"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/11/11/business/stem-web1/stem-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/11/business/stem-web1/stem-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-11-11T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Astellas Pharma", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Ocata Therapeutics Inc", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Stem Cells (Embryonic)", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": "International Business", "type_of_material": "News"}